Martin Glen

Before joining Parkwalk, Martin was a hedge fund manager for 15 years, investing in IPOs globally. He has been an extel-rated analyst, covering the chemical and pharmaceutical sectors at various institutions including Lazard, Lehman Brothers and Jeffries. Martin has a BA in Chemistry from Oxford University. Martin sits on the Boards of portfolio companies Cytora and Psyomics and is a Board Observer at Creavo Medical Technologies.